MEDERGIE LIMITED

Medergie Limited is a global leader in neuromodulation technologies, dedicated to developing and delivering cutting‑edge, patient‑friendly therapies that improve the quality of life for individuals worldwide. Based in Dublin, the company harnesses the power of mild electrical impulses to modulate the bioelectric flow of the nervous system, offering both implantable and non‑implantable solutions that are safe, reversible and highly effective.

The firm is actively establishing Centres of Excellence for neuromodulation across the globe and collaborates with renowned scientists, clinicians and neuromodulation experts on pioneering research projects. By integrating novel medical discoveries into new and existing devices, Medergie specialises in creating therapies that address a broad range of neurological conditions while prioritising patient wellbeing above all else.

Through its commitment to clinical, technical and commercial excellence, Medergie serves patients, healthcare providers and research organisations, delivering technologies that enhance clinical outcomes and set new standards in the rapidly expanding field of neuromodulation.